Half of newly developed drugs are the result of this 1983 Law

Details werden geladen...

https://kvia.com/stacker-medical-care/2026/07/21/half-of-newly-developed-drugs-are-the-result-of-this-1983-law/

Half of newly developed drugs are the result of this 1983 Law - KVIA

“Orphan” drugs were once a market almost no company wanted. Four decades later, they make up more than half of the new drugs the Food and Drug Administration approves. In 2024, the FDA’s drug center approved 50 new medicines. More than half of them (26 in all) were built to treat a rare disease.

Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy | The Manila Times

https://www.manilatimes.net/2026/06/29/tmt-newswire/globenewswire/satellos-receives-fda-fast-track-designation-for-sat-3247-for-the-treatment-of-duchenne-muscular-dystrophy/2374735

Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome | The Manila Times

https://www.manilatimes.net/2026/06/23/tmt-newswire/globenewswire/quoin-pharmaceuticals-receives-fda-conditional-approval-of-qyleki-as-the-proposed-brand-name-for-qrx003-for-netherton-syndrome/2370972

Registrieren

Half of newly developed drugs are the result of this 1983 Law - KVIA

Ähnliche Seiten

Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy | The Manila Times

Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome | The Manila Times